The U.S. broke a new record on Wednesday with more than 100,000 new cases of coronavirus confirmed in a single day. Johns Hopkins’ data showed 102,831 cases. (CNBC)
Healthcare regulators are analyzing Regeneron’s COVID-19 antibody treatment for potential emergency use authorization. The drug has been under review for a month and was given to President Donald Trump. (Reuters)
Biogen’s experimental Alzheimer’s drug has enough data to receive approval from the Food and Drug Administration. FDA staff said the drug’s late-stage trial results are “highly persuasive.” (CNBC)
Hospitalizations due to COVID-19 are surging in the U.S. There were record high hospitalizations in these states this week: Missouri, Oklahoma, Iowa, Indiana, Nebraska, North Dakota and New Mexico. (Associated Press)
Three healthcare policy pros explain what we can expect for healthcare under two very different presidential scenarios. Listen to the latest episode of The MM+M Podcast featuring Coalition for Healthcare Communication’s Jon Bigelow, GWU’s Dora Hughes and Alexion’s Tamar Thompson. (MM+M)
